Glaukos Reports Positive Phase 4 Results For IDose TR With Cataract Surgery
(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.